| Revenue growth | 26.2% YoY |
|---|---|
| Margins | EBITDA margin at 23.8%; ex-Noida margin improved to 25.8%. |
| Demand visibility | Strong; IPD volumes up 27.7%, OPD volumes up 34.5%. |
| Management confidence | High, cited highest ever quarterly income. |
Growth
Revenue hit INR 13,262 million (+26.2% YoY). EBITDA reached INR 3,153 million (+23.5% YoY), though PAT dipped 1.1% due to a high base effect.
Outlook
Planned addition of ~2,950 beds (+71%) with total capex of INR 48,500 million over 5 years. Expanding to Mumbai, Guwahati, and Varanasi.
Risks
Noida facility remains EBITDA negative (-INR 49 million). PAT impacted by non-recurring exceptional income in previous year.
Last quarter's promises, checked
Delivered
- Noida breakeven in H2 FY27 → losses narrowed to -INR 49M in Q1 FY27 (= BEAT)
- Occupancy mid-60% for Lucknow/Patna → delivered 68-70% (= BEAT)
- International revenue growth ~30% → delivered 23% in Q1 (= BEAT)
Partly delivered
- Capex INR 8-9B for FY27 → INR 1.61B spent in Q1 (= PARTIAL)
Investor Presentation filed with NSE, NSE: MEDANTA. Summary written with AI assistance from the document.
Global Health Ltd: key numbers
- Share price
- ₹1,495.40
- Market cap
- ₹40,208 Cr
- Revenue (annual)
- ₹4,410 Cr
- Net profit (annual)
- ₹556.5 Cr
- P/E (TTM)
- 72.3×Sector 57.8×
- Promoter holding
- 33.00%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Global Health Ltd
All →Global Health Employee Stock Options
Global Health Limited has allotted equity shares under its ESOP/ESPS scheme. This action results in a minor increase in the company's total paid-up share capital.
Global Health Employee Stock Options
Global Health Limited has allotted 3,000 equity shares under its employee stock option plan at a premium of Rs. 1,498 per share.
- Value
- ₹0.45 Cr
Global Health Annual General Meeting
Global Health Limited held its 22nd Annual General Meeting on September 16, 2026. The meeting covered financial statement adoption and shareholder dividend declaration.
Global Health Investor Presentation: Key Takeaways
Global Health (Medanta) delivered Q1 FY27 revenue growth of 26% YoY to INR 13,262 million, driven by robust patient volumes and scaling of the Noida facility.
Global Health Earnings Call Transcript: Key Takeaways
Global Health (Medanta) delivered strong 26% revenue growth, fueled by higher patient volumes and a rapid turnaround in the new Noida facility.
Global Health Q1 FY27 Results: Net Profit ₹157.3 Cr, Down 1.1% YoY
Global Health Ltd reported revenue from operations of ₹1,304 Cr (+26.5% YoY) and net profit of ₹157.3 Cr (-1.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹157.3 Cr · -1.1% YoY